[NICE Guideline] COVID-19 rapid guideline: critical care in adults

NICE | | COVID-19 rapid guideline: critical care in adults [NG159]

The purpose of this guideline is to maximise the safety of patients who need critical care during the COVID-19 pandemic, while protecting staff from infection. It will also enable services to make the best use of NHS resources.

On 31 March 2020, NICE amended the recommendations and algorithm to clarify when and how to use the Clinical Frailty Scale as part of a holistic assessment.


See a 1-page critical care referral algorithm to support decision making.


This guideline is for:

  • health and care practitioners
  • health and care staff involved in planning and delivering services
  • commissioners

The recommendations bring together

  • existing national and international guidance and policies
  • advice from specialists working in the NHS from across the UK. These include people with expertise and experience of treating patients for the specific health conditions covered by the guidance during the current COVID-19 pandemic.

NICE has developed these recommendations in direct response to the rapidly evolving situation and so could not follow the standard process for guidance development. The guideline has been developed using the interim process and methods for developing rapid guidelines on COVID-19. The recommendations are based on evidence and expert opinion and have been verified as far as possible. We will review and update the recommendations as the knowledge base and expert experience develops.

Full details from NICE

NICE Consultation: Multiple sclerosis in adults: management

NICE |  January  2019 | Multiple sclerosis in adults: management In development [GID-NG10153]

NICE has released draft guidance on Multiple sclerosis in adults: management

NICE has opened consultation for comment on this draft scope. The scope defines what the guideline will (and will not) cover.

The consultation closes on Monday 17 February 2020 at 5 pm.

Full details from NICE 

[NICE Guideline] Acute kidney injury: prevention, detection and management

NICE | December  2019 | Acute kidney injury: prevention, detection and management

NICE has published Acute kidney injury: prevention, detection and management  [NG148], this guideline covers preventing, detecting and managing acute kidney injury in children, young people and adults. It aims to improve assessment and detection by non-specialists, and specifies when people should be referred to specialist services. This will improve early recognition and treatment, and reduce the risk of complications in people with acute kidney injury.

Full details from NICE 

NICE Guideline update: Menopause: diagnosis and management

NICE | December 2019 | Menopause: diagnosis and management |[NG23]

This guideline covers the diagnosis and management of menopause, including in women who have premature ovarian insufficiency. The guideline aims to improve the consistency of support and information provided to women in menopause.

 In December 2019, in response to an MHRA safety alert on hormone replacement therapy (HRT) and the risk of breast cancer, NICE replaced the table in the recommendation on breast cancer risk with a link to the MHRA’s advice on HRT risks and benefits. NICE will also update this recommendation as part of the planned update to the guideline.

Full details from NICE 

Maternity And Neonatal Care

New report finds that regularly monitoring women who are pregnant with twins or triplets, to spot any possible complications, can lead to better outcomes for mothers and their babies| National Institute for Health and Care Excellence (NICE) 

This report focuses on how NICE’s evidence-based guidance contributes to improvements in maternity and neonatal care. It finds that if all maternity units applied NICE’s recommendations on twin and triplet pregnancies, such as labelling the fetuses during scans so they can be told apart and monitored closely for complications, it could lead to 634 fewer emergency caesarean sections and 1,308 fewer neonatal admissions in England, per year. This could mean preventing around one in ten neonatal admissions of babies from multiple births in the UK each year.